IBDEI1CQ ; ; 12-AUG-2014
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;MAY 15, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,24220,2)
 ;;=^48340
 ;;^UTILITY(U,$J,358.3,24221,0)
 ;;=991.2^^155^1539^26
 ;;^UTILITY(U,$J,358.3,24221,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,24221,1,4,0)
 ;;=4^Frostbite Of Foot
 ;;^UTILITY(U,$J,358.3,24221,1,5,0)
 ;;=5^991.2
 ;;^UTILITY(U,$J,358.3,24221,2)
 ;;=^276237
 ;;^UTILITY(U,$J,358.3,24222,0)
 ;;=991.1^^155^1539^27
 ;;^UTILITY(U,$J,358.3,24222,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,24222,1,4,0)
 ;;=4^Frostbite Of Hand
 ;;^UTILITY(U,$J,358.3,24222,1,5,0)
 ;;=5^991.1
 ;;^UTILITY(U,$J,358.3,24222,2)
 ;;=^276235
 ;;^UTILITY(U,$J,358.3,24223,0)
 ;;=991.4^^155^1539^37
 ;;^UTILITY(U,$J,358.3,24223,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,24223,1,4,0)
 ;;=4^Immersion Foot
 ;;^UTILITY(U,$J,358.3,24223,1,5,0)
 ;;=5^991.4
 ;;^UTILITY(U,$J,358.3,24223,2)
 ;;=^61358
 ;;^UTILITY(U,$J,358.3,24224,0)
 ;;=V70.5^^155^1539^30
 ;;^UTILITY(U,$J,358.3,24224,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,24224,1,4,0)
 ;;=4^Health Exam-Group Survey
 ;;^UTILITY(U,$J,358.3,24224,1,5,0)
 ;;=5^V70.5
 ;;^UTILITY(U,$J,358.3,24224,2)
 ;;=^295595
 ;;^UTILITY(U,$J,358.3,24225,0)
 ;;=250.00^^155^1539^22
 ;;^UTILITY(U,$J,358.3,24225,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,24225,1,4,0)
 ;;=4^Dmii w/o Cmp Nt St Uncntr
 ;;^UTILITY(U,$J,358.3,24225,1,5,0)
 ;;=5^250.00
 ;;^UTILITY(U,$J,358.3,24225,2)
 ;;=^331779
 ;;^UTILITY(U,$J,358.3,24226,0)
 ;;=585.4^^155^1539^13
 ;;^UTILITY(U,$J,358.3,24226,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,24226,1,4,0)
 ;;=4^Chr Kidney Dis Stage IV
 ;;^UTILITY(U,$J,358.3,24226,1,5,0)
 ;;=5^585.4
 ;;^UTILITY(U,$J,358.3,24226,2)
 ;;=^332810
 ;;^UTILITY(U,$J,358.3,24227,0)
 ;;=202.80^^155^1539^41
 ;;^UTILITY(U,$J,358.3,24227,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,24227,1,4,0)
 ;;=4^Lymphoma Nec Unspec Site
 ;;^UTILITY(U,$J,358.3,24227,1,5,0)
 ;;=5^202.80
 ;;^UTILITY(U,$J,358.3,24227,2)
 ;;=^87701
 ;;^UTILITY(U,$J,358.3,24228,0)
 ;;=782.2^^155^1539^40
 ;;^UTILITY(U,$J,358.3,24228,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,24228,1,4,0)
 ;;=4^Local Suprficial Swellng
 ;;^UTILITY(U,$J,358.3,24228,1,5,0)
 ;;=5^782.2
 ;;^UTILITY(U,$J,358.3,24228,2)
 ;;=^71690
 ;;^UTILITY(U,$J,358.3,24229,0)
 ;;=401.9^^155^1539^35
 ;;^UTILITY(U,$J,358.3,24229,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,24229,1,4,0)
 ;;=4^Hypertension NOS
 ;;^UTILITY(U,$J,358.3,24229,1,5,0)
 ;;=5^401.9
 ;;^UTILITY(U,$J,358.3,24229,2)
 ;;=^186630
 ;;^UTILITY(U,$J,358.3,24230,0)
 ;;=355.9^^155^1539^44
 ;;^UTILITY(U,$J,358.3,24230,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,24230,1,4,0)
 ;;=4^Mononeuritis NOS
 ;;^UTILITY(U,$J,358.3,24230,1,5,0)
 ;;=5^355.9
 ;;^UTILITY(U,$J,358.3,24230,2)
 ;;=^78915
 ;;^UTILITY(U,$J,358.3,24231,0)
 ;;=171.9^^155^1539^42
 ;;^UTILITY(U,$J,358.3,24231,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,24231,1,4,0)
 ;;=4^Mal Neo Soft Tissue NOS
 ;;^UTILITY(U,$J,358.3,24231,1,5,0)
 ;;=5^171.9
 ;;^UTILITY(U,$J,358.3,24231,2)
 ;;=^267165
 ;;^UTILITY(U,$J,358.3,24232,0)
 ;;=117.9^^155^1539^45
 ;;^UTILITY(U,$J,358.3,24232,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,24232,1,4,0)
 ;;=4^Mycoses NOS
 ;;^UTILITY(U,$J,358.3,24232,1,5,0)
 ;;=5^117.9
 ;;^UTILITY(U,$J,358.3,24232,2)
 ;;=^87308
 ;;^UTILITY(U,$J,358.3,24233,0)
 ;;=415.19^^155^1539^50
 ;;^UTILITY(U,$J,358.3,24233,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,24233,1,4,0)
 ;;=4^Oth Pulm Emb & Infarc
 ;;^UTILITY(U,$J,358.3,24233,1,5,0)
 ;;=5^415.19
 ;;^UTILITY(U,$J,358.3,24233,2)
 ;;=^303285
 ;;^UTILITY(U,$J,358.3,24234,0)
 ;;=780.60^^155^1539^24
 ;;^UTILITY(U,$J,358.3,24234,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,24234,1,4,0)
 ;;=4^Fever NOS
